limiting step of renin-angiotensin system that is associated with blood pressure. Thus Ligand
and structure-based pharmacophore models were developed in this study to identify new
potential leads inhibiting this rate-limiting enzyme as an efficient way to treat blood pressure.
X-ray predicted binding modes of most active compounds were used in ligand-based
approach whereas the 3D structural information of renin was used in structure-based …